Chemistry: analytical and immunological testing – Peptide – protein or amino acid
Reexamination Certificate
2003-12-11
2004-11-09
Wallenhorst, Maureen M. (Department: 1743)
Chemistry: analytical and immunological testing
Peptide, protein or amino acid
C436S169000, C422S051000, C422S051000
Reexamination Certificate
active
06815210
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates generally to methods and devices of detecting proteins. Specifically, the invention is directed to methods and devices for detecting proteins at lower pH's using various buffers.
BACKGROUND OF THE INVENTION
Methods for the detection of urinary proteins are often more sensitive to albumin than to other urinary proteins. It is important, however, to detect proteins other than albumin, especially in the case of Bence-Jones proteinuria. The detection of proteins should cover a wide range of protein concentrations since the decision levels and recommended actions to be taken by clinicians will vary depending on the concentration of protein detected in a patient's urine. For example, persistent proteinuria greater than 50 mg/dL represents strong evidence of renal disease whereas a protein level of greater than 300 mg/dL is consistent with a diagnosis of nephrotic syndrome. A concentration of protein in urine of greater than 800 mg/dL suggests massive protein loss and warrants a renal biopsy and/or steroid therapy. Accordingly, it is apparent that a test for protein in urine should be effective over a wide range of protein values.
Various methods for the determination of protein in aqueous fluid have been reported in the literature. These methods include the Kjeldahl method, biuret method, Lowery method, dyestuff combination method, UV method and fluorometric method. In general, proteins react with various substance including dyes such as bromphenol blue, coomassie brilliant blue and eosine, as well as metal ions such as silver (I), copper (II), zinc (II) and lead (II).
Urine contains amounts of salt that vary between individuals. Some of these salts may act as a buffer when a diagnostic assay demands operation at a pH different than that of the urine sample. For example, urine sample with salts such as bicarbonate, acetate or phosphate tend to resist the lowering of pH. Creatinine, a common component of urine, may also act as a buffer in resisting the lowering of pH. The result of this buffering is that some urine samples will cause a strip pH to be higher than optimal. A higher than optimal strip pH may result in color generation of the protein indicator dyes, providing a false indication of the presence of protein. It is desired to have a buffing system that reduces such urine effects, while not interacting with the chemistry occurring.
Accordingly, a need exists for a method and device for detecting proteins over a wide range of clinical concentrations and pH's.
SUMMARY OF THE INVENTION
According to one embodiment, an assay for the determination of protein in an aqueous test fluid comprises combining the test fluid with a buffer and a dye. The buffer is selected from citrulline, malonic acid, cyanoacetic acid, citraconic acid, methyl phosphonic acid, sarcosine, saccharin, or combinations thereof. The buffer is added in sufficient quantity to maintain the pH of the assay including the test fluid at a selected target pH range within a range of from about 2.0 to about 3.0. The dye has a pKa which is enables it to operate as a protein indicator at the target pH range. The dye has an affinity for protein such that it will provide a detectable response in the presence of greater than about 15 mg/dL protein, to thereby render the assay suitable for the detection of total protein in the test fluid.
According to another embodiment, a dry device for use in determining protein levels in a fluid test sample comprises an absorbent material having absorbed therein a buffer and a dye. The buffer is selected from citrulline, malonic acid, cyanoacetic acid, citraconic acid, methyl phosphonic acid, sarcosine, saccharin, or combinations thereof. The buffer is added in sufficient quantity to maintain the pH of the assay including the test fluid at a selected target pH range within a range of from about 2.0 to about 3.0. The dye has a pKa which enables it to operate as a protein indicator at the target pH range. The dye has an affinity for protein such that it will provide a detectable response in the presence of greater than 15 mg/dL protein upon contact between the device and the fluid test sample, to thereby render the device suitable for the detection of total protein in the fluid test sample.
According to a further embodiment, an assay for the determination of protein in an aqueous test fluid comprises combining the test fluid with a buffer and a dye. The buffer is selected from citrulline, malonic acid, or combinations thereof The buffer is added in sufficient quantity to maintain the pH of the assay including the test fluid at a selected target pH range within a range of from about 2.0 to about 3.0. The dye has a pKa which enables it to operate as a protein indicator at the target pH range and which has an affinity for protein such that it will provide a detectable response in the presence of greater than about 15 mg/dL protein, to thereby render the assay suitable for the detection of total protein in the test fluid.
According to yet a further embodiment, a dry device for use in determining protein levels in a fluid test sample comprises an absorbent material having absorbed therein a buffer and a dye. The buffer is selected from citrulline, malonic acid or combinations thereof. The buffer is added in sufficient quantity to maintain the pH of the assay including the test fluid within a selected target pH range within a range of from about 2.0 to about 3.0. The dye has a pKa which enables it to operate as a protein indicator at the target pH range and which has affinity for protein such that it will provide a detectable response in the presence of greater than 15 mg/dL protein upon contact between the device and the fluid test sample, to thereby render the device suitable for the detection of total protein in the fluid test sample.
REFERENCES:
patent: 3438737 (1969-04-01), Atkinson
patent: 3485587 (1969-12-01), Keston
patent: 5077222 (1991-12-01), Lau
patent: 5087575 (1992-02-01), Lau
patent: 5279790 (1994-01-01), Corey et al.
patent: 5326707 (1994-07-01), Franke et al.
patent: 5399498 (1995-03-01), Pugia
patent: 5424125 (1995-06-01), Ballard et al.
patent: 5424215 (1995-06-01), Albarella et al.
patent: 5593895 (1997-01-01), Cahill et al.
patent: 5716851 (1998-02-01), Pugia et al.
patent: 5750405 (1998-05-01), Albarella et al.
patent: 5908787 (1999-06-01), Cast et al.
patent: 0361244 (1990-04-01), None
patent: 0785429 (1997-07-01), None
patent: 0907081 (1999-04-01), None
patent: 0877251 (2002-11-01), None
patent: 04361160 (1992-12-01), None
“Clinical Nephrology Meetings 2001”; National Kidney Foundation; pp. 1, 2, 21, 207 & A20, Orlando, Florida, Apr. 2001.
Profitt, J. et al., “The Relative Utility or Urinary Total Protein and Albumin Dipstick Measurement In the Identification of Patients with Myleoma and Tubular Proteinuria”,Am. J. Kidney Dis., 37(4) A27 (2001).
Pugia, M.J. et al., “Screening for Proteinuria in Japanese School Children: A New Approach”,Clin. Chem. Lab. Med., 38/10 pp. 975-982 (2000).
Pugia, M.J. “Technology Behind Diagnostic Reagent Strips”,Lab Medicine, 31/2, pp. 92-96 (2000).
Pugia, M.J. et al., “High Sensitivity Dye Binding Assay for Albumin in Urine”,J. Clin. Lab. Analysis, 13/4, pp. 180-187 (1999).
Pugia, M.J. et al., “Screening School Children for Albuminuria; Proteinuria and Occult Blood with Dipsticks”,Clin Chem Lab Med, 37/2, pp. 149-157 (1999).
Pugia, M.J. et al., “Encyclopedia of Urinalysis, Chapter 5b. New Developments in Urinalysis Strip Tests for Proteins” (date unknown).
Pugia, M.J. et al., “Comparison of Instrument-Read Dipsticks for Albumin and Creatinine in Urine With Visual Results and Quantitative Methods”,J. Clin Lab Analysis, 12/5, pp. 280-284 (1998).
Sasaki, M. et al., “Measurement of the Albumin Content of Urinary Protein Using Dipsticks”,J. Clin. Lab. Analysis, 13/5, pp. 246-250 (1999).
Watanabe, N. et al., “Urinary Protein as Measured with a Pyrogallol Red-Molybdate Complex, Manually and in a Hitachi 726 Automated Analyzer”,Clin. Chem. 32/8 pp. 1551-1554 (1986).
Farr Jennifer
Orn Alexander H.
Profitt James A.
Bayer Healthcare LLC
Wallenhorst Maureen M.
LandOfFree
Total protein detection methods and devices does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Total protein detection methods and devices, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Total protein detection methods and devices will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3360414